News
-
-
-
PRESS RELEASE
P&P Group sells another project with 121 flats in the German City of Nuremberg and successfully concludes the 2024 financial year - Completion of the property is already planned for the end of 2025
P&P Group sells 121-unit residential project in Nuremberg, completing 2024 successfully. Property planned for completion by end of 2025 in sought-after location -
-
-
PRESS RELEASE
BIOVERSYS ANNOUNCES INTENTION TO FLOAT ON THE SIX SWISS EXCHANGE
BioVersys AG announces intention to float on SIX Swiss Exchange, targeting primary-only proceeds of approx. CHF 80 million to advance lead asset BV100 through Phase 3 and finance operating expenses. IPO supported by AMR Action Fund and GSK -
-
PRESS RELEASE
Kontron expects further revenue growth and a disproportionately high increase in operating earnings in 2025
Kontron anticipates revenue growth and significant increase in operating earnings for 2025, with preliminary 2024 results exceeding expectations. Strong momentum expected from IoT innovations -
REGULATED PRESS RELEASE
Biophytis and AskHelpU Sign a Co-Development Agreement in Rare Neuromuscular Diseases in China
Biophy's and AskHelpU sign a co-development agreement for rare neuromuscular diseases in China. The agreement aims to evaluate BIO101's efficacy in ALS, potentially offering a major therapeutic solution for patients -
